Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for bioMerieux (BMXMF : OTC)

• Company Description    bioM?rieux S.A. designs, develops, manufactures and markets systems in the field of vitro diagnostics. The company provides diagnostic solutions which determine the source of disease and contamination. It also offers solutions for managing infectious diseases, cancers and cardiovascular diseases in clinical applications. The company provides solutions for the enumeration of microbial flora, detection of specific pathogenic bacteria, monitoring of air and surface quality and sterility testing for the agri-food, cosmetics and pharmaceutical industries. bioM?rieux S.A. is based in Marcy L Etoile, France. Number of Employees: 14,600

• Price / Volume Information    Yesterday's Closing Price: $142.45 Daily Weekly Monthly 20 Day Moving Average: 3 shares Shares Outstanding: 118.36 (millions) Market Capitalization: $16,860.55 (millions) Beta: 0.74 52 Week High: $143.47 52 Week Low: $96.54 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 6.11% 2.21% 12 Week 15.21% -7.38% Year To Date 34.15% 27.30%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 376 Chemin De l`Orme - Marcy l'Etoile,I0 69280 FRA ph: 33-04-78-87-20-00 fax: 33-04-78-87-20-90 investor.relations@biomerieux.com http://www.biomerieux.com

• General Corporate Information    Officers Pierre Boulud - Chief Executive Officer Alexandre Merieux - Chairman of the Board of Directors Guillaume Bouhours - Chief Financial Officer;Executive Vice President;P Charles K. Cooper - Executive Vice President;Chief Medical Officer Philippe Archinard - Director Peer Information bioMerieux (CHCR) bioMerieux (ESRX) bioMerieux (MYDP) bioMerieux (COR) bioMerieux (GBCS) bioMerieux (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: F1149Y232 SIC: 8880 Fiscal Year Fiscal Year End: December Last Reported Quarter: - Next Expected EPS Date: 07/04/25 Share - Related Items Shares Outstanding: 118.36 Most Recent Split Date: 9.00 (3.00:1) Beta: 0.74 Market Capitalization: $16,860.55 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 07/04/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 3.70 Price/Cash Flow: 31.79 Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 06/30/25 - - 03/31/25 - - 12/31/24 - - ROA 06/30/25 - - 03/31/25 - - 12/31/24 - - Current Ratio 06/30/25 - - 03/31/25 - - 12/31/24 - 2.20 Quick Ratio 06/30/25 - - 03/31/25 - - 12/31/24 - 1.29 Operating Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Pre-Tax Margin 06/30/25 - - 03/31/25 - - 12/31/24 - 14.56 Book Value 06/30/25 - - 03/31/25 - - 12/31/24 - 38.50 Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - 1.73 Debt-to-Equity 06/30/25 - - 03/31/25 - - 12/31/24 - 0.08 Debt-to-Capital 06/30/25 - - 03/31/25 - - 12/31/24 - 7.66

Powered by Zacks Investment Research ©